Success Metrics

Active Trials
8(67%)

Phase Distribution

Ph early_phase_1
3
25%
Ph phase_2
7
58%
Ph phase_3
2
17%

Phase Distribution

3

Early Stage

7

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
3(25.0%)
Phase 2Efficacy & side effects
7(58.3%)
Phase 3Large-scale testing
2(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

8

trials recruiting

Total Trials

12

all time

Status Distribution
Active(12)

Detailed Status

Recruiting7
Not yet recruiting4
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
8
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Early Phase 13 (25.0%)
Phase 27 (58.3%)
Phase 32 (16.7%)

Trials by Status

active_not_recruiting18%
recruiting758%
not_yet_recruiting433%

Recent Activity

8 active trials
Showing 5 of 12
recruitingphase_2

Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD

NCT06902974
not_yet_recruitingphase_3

Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder

NCT06943573
active_not_recruitingphase_3

Psilocybin for Major Depressive Disorder (MDD)

NCT06308653
not_yet_recruitingearly_phase_1

Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS)

NCT06760533
recruitingearly_phase_1

Psilocybin for Prolonged Grief Disorder

NCT06724289
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT06902974Phase 2

Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD

Recruiting
NCT06943573Phase 3

Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder

Not Yet Recruiting
NCT06308653Phase 3

Psilocybin for Major Depressive Disorder (MDD)

Active Not Recruiting
NCT06760533Early Phase 1

Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS)

Not Yet Recruiting
NCT06724289Early Phase 1

Psilocybin for Prolonged Grief Disorder

Recruiting
NCT07405606Phase 2

Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder

Not Yet Recruiting
NCT07306364Phase 2

Psilocybin-Assisted Physical Therapy in Chronic Low Back Pain

Not Yet Recruiting
NCT06899594Early Phase 1

Psilocybin for Methamphetamine Addiction

Recruiting
NCT06853912Phase 2

Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)

Recruiting
NCT06512220Phase 2

Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)

Recruiting
NCT06518720Phase 2

Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)

Recruiting
NCT05710237Phase 2

Does Psilocybin Require Psychedelic Effects to Treat Depression?

Recruiting

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12